Medical Dosimetry
Volume 32, Issue 4 , Pages 254-262 , Winter 2007

Impact of Increasing Margin Around the Lumpectomy Cavity to Define the Planning Target Volume for 3D Conformal External Beam Accelerated Partial Breast Irradiation

Presented in part at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), October 16–20, 2005, Denver, CO as a poster presentation.

  • Brett W. Cox, M.D.

      Affiliations

    • Department of Radiation Oncology, Stanford University, Stanford, CA
    • ,
  • Kathleen C. Horst, M.D.

      Affiliations

    • Department of Radiation Oncology, Stanford University, Stanford, CA
    • Corresponding Author InformationReprint requests to: Kathleen C. Horst, M.D., 875 Blake Wilbur Drive, CC-G221A, Stanford, CA 94305-5847.
    • ,
  • Sherri Thornton, C.M.D.

      Affiliations

    • Department of Radiation Oncology, Stanford University, Stanford, CA
    • ,
  • Frederick M. Dirbas, M.D.

      Affiliations

    • Department of Surgery, Stanford University, Stanford, CA

Received 18 January 2007 ,Accepted 9 February 2007.

References 

  1. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update (Ontario Clinical Oncology Group). J. Natl. Cancer Inst. 1996;88:1659–1664
  2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. [see comment] N. Engl. J. Med. 2002;347:1233–1241
  3. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. [see comment] J Clin. Oncol. 2002;20:4141–4149
  4. Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial (Scottish Cancer Trials Breast Group). [see comment] Lancet. 1996;348:708–713
  5. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. [see comment] N. Engl. J. Med. 2004;351:963–970
  6. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. [see comment] N. Engl. J. Med. 2004;351:971–977
  7. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. [see comment] J. Clin. Oncol. 1999;17:2326–2333
  8. Malmstrom P, Holmberg L, Anderson H, et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: A randomised clinical trial in a population with access to public mammography screening. Eur. J. Cancer. 2003;39:1690–1697
  9. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann. Oncol. 2001;12:997–1003
  10. Rosen PP, Fracchia AA, Urban JA, et al. “Residual” mammary carcinoma following simulated partial mastectomy. Cancer. 1975;35:739–747
  11. Fisher B, Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials (National Surgical Adjuvant Breast and Bowel Project). World J. Surg. 1994;18:63–69
  12. Uppsala-Orebro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer (A randomized trial). J. Natl. Cancer Inst. 1990;82:277–282
  13. Clark RM, McCulloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J. Natl. Cancer Inst. 1992;84:683–689
  14. Baglan KL, Martinez AA, Frazier RC, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 2001;50:1003–1011
  15. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am. J. Surg. 2000;180:299–304
  16. Lawenda BD, Taghian AG, Kachnic LA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int. J. Radiat. Oncol. Biol. Phys. 2003;56:671–680
  17. Polgar C, Major T, Somogyi A, et al. [Brachytherapy of the tumor bed after breast conserving surgery: New radiotherapeutic option in the management of early breast cancer]. Orvosi. Hetilap. 1999;140:1461–1466
  18. Arthur DW, Koo D, Zwicker RD, et al. Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience. Int. J. Radiat. Oncol. Biol. Phys. 2003;56:681–689
  19. Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: A method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006;106:991–999
  20. Vicini FA, Beitsch PD, Quiet CA, et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: Results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer. 2005;104:1138–1148
  21. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. [see comment] Int. J. Radiat. Oncol. Biol. Phys. 2003;55:289–293
  22. Vaidya JS, Baum M, Tobias JS, et al. Targeted intra-operative radiotherapy (Targit): An innovative method of treatment for early breast cancer. Ann. Oncol. 2001;12:1075–1080
  23. Veronesi U, Gatti G, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch. Surg. 2003;138:1253–1256
  24. Formenti SC, Truong MT, Goldberg JD, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: Preliminary clinical results and dose-volume histogram analysis. Int. J. Radiat. Oncol. Biol. Phys. 2004;60:493–504
  25. Vicini F, Winter K, Straube W, et al. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: Initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int. J. Radiat. Oncol. Biol. Phys. 2005;63:1531–1537
  26. Vicini FA, Remouchamps V, Wallace M, et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. [see comment] Int. J. Radiat. Oncol. Biol. Phys. 2003;57:1247–1253
  27. Taghian AG, Kozak KR, Doppke KP, et al. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2006;64:1092–1099
  28. Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int. J. Radiat. Oncol. Biol. Phys. 2004;60:722–730
  29. Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int. J. Radiat. Oncol. Biol. Phys. 2003;55:302–311
  30. NSABP Protocol B-39/RTOG Protocol 0413. A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer. Available at: http://www.rtog.org/members/protocols/0413/0413.pdf. Accessed March 19, 2007.
  31. Frazier RC, Vicini FA, Sharpe MB, et al. Impact of breathing motion on whole breast radiotherapy: A dosimetric analysis using active breathing control. Int. J. Radiat. Oncol. Biol. Phys. 2004;58:1041–1047
  32. Korreman SS, Pedersen AN, Nottrup TJ, et al. Breathing adapted radiotherapy for breast cancer: Comparison of free breathing gating with the breath-hold technique. Radiother. Oncol. 2005;76:311–318
  33. Smith RP, Bloch P, Harris EE, et al. Analysis of interfraction and intrafraction variation during tangential breast irradiation with an electronic portal imaging device. Int. J. Radiat. Oncol. Biol. Phys. 2005;62:373–378
  34. Vicini F, Baglan K, Kestin L, et al. The emerging role of brachytherapy in the management of patients with breast cancer. Semin. Radiat. Oncol. 2002;12:31–39
  35. Weed DW, Edmundson GK, Vicini FA, et al. Accelerated partial breast irradiation: A dosimetric comparison of three different techniques. Brachytherapy. 2005;4:121–129

PII: S0958-3947(07)00047-7

doi: 10.1016/j.meddos.2007.02.003

Medical Dosimetry
Volume 32, Issue 4 , Pages 254-262 , Winter 2007

Article Tools